BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 15617098)

  • 1. Dietary factors and the regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase: implications for breast cancer and development.
    Duncan RE; El-Sohemy A; Archer MC
    Mol Nutr Food Res; 2005 Feb; 49(2):93-100. PubMed ID: 15617098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Geraniol and beta-ionone inhibit proliferation, cell cycle progression, and cyclin-dependent kinase 2 activity in MCF-7 breast cancer cells independent of effects on HMG-CoA reductase activity.
    Duncan RE; Lau D; El-Sohemy A; Archer MC
    Biochem Pharmacol; 2004 Nov; 68(9):1739-47. PubMed ID: 15450939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Requirement for mevalonate in the control of proliferation of human breast cancer cells.
    Wejde J; Blegen H; Larsson O
    Anticancer Res; 1992; 12(2):317-24. PubMed ID: 1580550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proto oncogene/eukaryotic translation initiation factor (eIF) 4E attenuates mevalonate-mediated regulation of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase synthesis.
    Buechler RD; Peffley DM
    Mol Carcinog; 2004 Sep; 41(1):39-53. PubMed ID: 15352124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulatory role of mevalonate in the growth of normal and neoplastic human mammary epithelial cells.
    Larsson O; Blegen H
    Anticancer Res; 1993; 13(4):1075-9. PubMed ID: 8352528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of HMG-CoA reductase in MCF-7 cells by genistein, EPA, and DHA, alone and in combination with mevastatin.
    Duncan RE; El-Sohemy A; Archer MC
    Cancer Lett; 2005 Jun; 224(2):221-8. PubMed ID: 15914273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of isoprenoids on growth of normal human mammary epithelial cells and breast cancer cells in vitro.
    Larsson O
    Anticancer Res; 1994; 14(1A):123-8. PubMed ID: 8166438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tocotrienols potentiate lovastatin-mediated growth suppression in vitro and in vivo.
    McAnally JA; Gupta J; Sodhani S; Bravo L; Mo H
    Exp Biol Med (Maywood); 2007 Apr; 232(4):523-31. PubMed ID: 17392488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Posttranscriptional regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase in lens epithelial cells by mevalonate-derived nonsterols.
    Cenedella RJ
    Exp Eye Res; 1997 Jul; 65(1):63-72. PubMed ID: 9237866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Statins and cancer development.
    Duncan RE; El-Sohemy A; Archer MC
    Cancer Epidemiol Biomarkers Prev; 2005 Aug; 14(8):1897-8. PubMed ID: 16103434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isopentenoid synthesis in eukaryotic cells. An initiating role for post-translational control of 3-hydroxy-3-methylglutaryl coenzyme A reductase.
    Giron MD; Havel CM; Watson JA
    Arch Biochem Biophys; 1993 Apr; 302(1):265-71. PubMed ID: 8097083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of geraniol on fatty-acid and mevalonate metabolism in the human hepatoma cell line Hep G2.
    Polo MP; de Bravo MG
    Biochem Cell Biol; 2006 Feb; 84(1):102-11. PubMed ID: 16462894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The key enzyme of cholesterol synthesis pathway: HMG-CoA reductase and disease].
    Wang W; Tong TJ
    Sheng Li Ke Xue Jin Zhan; 1999 Jan; 30(1):5-9. PubMed ID: 12532841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies of the isoprenoid-mediated inhibition of mevalonate synthesis applied to cancer chemotherapy and chemoprevention.
    Mo H; Elson CE
    Exp Biol Med (Maywood); 2004 Jul; 229(7):567-85. PubMed ID: 15229351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isoprenoid-mediated inhibition of mevalonate synthesis: potential application to cancer.
    Elson CE; Peffley DM; Hentosh P; Mo H
    Proc Soc Exp Biol Med; 1999 Sep; 221(4):294-311. PubMed ID: 10460692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mevalonate is essential for growth activation of human fibroblasts: evidence for a critical role of protein glycosylation in the prereplicative period.
    Carlberg M; Hjertman M; Wejde J; Larsson O
    Exp Cell Res; 1994 Jun; 212(2):359-66. PubMed ID: 8187830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modification of phospholipids fatty acid composition in reuber H35 hepatoma cells: effect on HMG-CoA reductase activity.
    García-Pelayo MC; García-Peregrín E; Martínez-Cayuela M
    J Cell Biochem; 2003 Oct; 90(3):586-91. PubMed ID: 14523992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mevalonate-suppressive dietary isoprenoids for bone health.
    Mo H; Yeganehjoo H; Shah A; Mo WK; Soelaiman IN; Shen CL
    J Nutr Biochem; 2012 Dec; 23(12):1543-51. PubMed ID: 22981371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The mevalonate pathway: importance in mesangial cell biology and glomerular disease.
    O'Donnell MP; Kasiske BL; Kim Y; Atluru D; Keane WF
    Miner Electrolyte Metab; 1993; 19(3):173-9. PubMed ID: 8232104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of biosynthesis of cholesterol and isoprenoid derivatives in regulation of G1 progression and cell proliferation of 3T6 cells.
    Larsson O
    J Cell Physiol; 1987 Oct; 133(1):163-8. PubMed ID: 3667703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.